Figure. KEAP1-deficient lung cancer cells use PC-dependent metabolism as a metabolic escape route during KRAS G12C inhibition. Blocking PC restores sensitivity to treatment. (IMAGE)

Kanazawa University

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.